Drug Trial Radar · NCT06153966
PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717
Last checked: Nov 19, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
85
Actual
Start
Jan 4, 2024
Primary completion
Apr 2027
Study completion Aug 2030
Sponsor
- Lead sponsor
- Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
- Sponsor type
- Industry
- First posted
- Dec 1, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of intrathecal (IT) delivery of ION717.
Conditions
- Prion Disease
Interventions
ION717Drug
ION717 will be administered by IT injection.
PlaceboDrug
Placebo-matching ION717 will be administered by IT injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent adverse events.Time frame: Baseline up to Week 33
Locations
13 sites in 9 countries. Site status is shown where the registry gives one.
Massachusetts General Hospital
Boston, Massachusetts
NYU Langone Health
New York, New York
University Hospitals Cleveland Medical Center
Cleveland, Ohio
Royal Melbourne Hospital
Parkville, Australia
McGill University Health Centre
Montreal, Quebec, Canada
Hôpital Universitaire Pitié Salpêtrière
Paris, France
University Medical Center Göttingen
Göttingen, Germany
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Milan, Italy
Mihara Memorial Hospital
Gunma, Isesaki-shi, Japan
National Center of Neurology and Psychiatry
Tokyo, Kodaira-shi, Japan
Neuromuscular Center Yoshimizu Hospital
Yamaguchi, Shimonoseki-shi, Japan
Hospital Clinic De Barcelona
Barcelona, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.